These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10976661)

  • 21. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.
    Harrison I; Joyce EM; Mutsatsa SH; Hutton SB; Huddy V; Kapasi M; Barnes TR
    Psychol Med; 2008 Jan; 38(1):79-88. PubMed ID: 17532864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance abuse in schizophrenia. A Singapore perspective.
    Verma SK; Subramaniam M; Chong SA; Kua EH
    Soc Psychiatry Psychiatr Epidemiol; 2002 Jul; 37(7):326-8. PubMed ID: 12111024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
    Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
    J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
    Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
    Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH; Kim D; Park SH; Lee HB; Chung EK
    J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes.
    Bühler B; Hambrecht M; Löffler W; an der Heiden W; Häfner H
    Schizophr Res; 2002 Apr; 54(3):243-51. PubMed ID: 11950549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study.
    Mancini-Marïe A; Potvin S; Fahim C; Beauregard M; Mensour B; Stip E
    J Clin Psychiatry; 2006 Mar; 67(3):342-50. PubMed ID: 16649818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study.
    Cuffel BJ; Chase P
    J Nerv Ment Dis; 1994 Jun; 182(6):342-8. PubMed ID: 8201306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cognitive impairment and substance abuse on psychiatric hospitalizations.
    Jackson CT; Fein D; Essock SM; Mueser KT
    Community Ment Health J; 2001 Aug; 37(4):303-12. PubMed ID: 11482748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.
    Cantor-Graae E; Nordström LG; McNeil TF
    Schizophr Res; 2001 Mar; 48(1):69-82. PubMed ID: 11278155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of schizophrenic patients with or without coexisting substance use disorder.
    Farris C; Brems C; Johnson ME; Wells R; Burns R; Kletti N
    Psychiatr Q; 2003; 74(3):205-22. PubMed ID: 12918597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
    Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
    Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.